3-[(2,4-DIMETHYLPHENOXY)METHYL]PIPERIDINE
![3-[(2,4-DIMETHYLPHENOXY)METHYL]PIPERIDINE price.](/StructureFile/ChemBookStructure21/GIF/CB1817920.gif)
|
- $205 - $648
- Product name: 3-[(2,4-DIMETHYLPHENOXY)METHYL]PIPERIDINE
- CAS: 946713-14-0
- MF: C14H21NO
- MW: 219.32
- EINECS:
- MDL Number:MFCD08687649
- Synonyms:3-[(2,4-DIMETHYLPHENOXY)METHYL]PIPERIDINE;Piperidine, 3-[(2,4-dimethylphenoxy)methyl]-
4 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 500.00mg
- 500mg
- 5g
- ManufacturerCrysdot
- Product numberCD11006198
- Product description3-((2,4-Dimethylphenoxy)methyl)piperidine 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11006198
- Product description3-((2,4-Dimethylphenoxy)methyl)piperidine 97%
- Packaging5g
- Price$648
- Updated2026-05-26
- Buy
- ManufacturerMatrix Scientific
- Product number022995
- Product description3-[(2,4-Dimethylphenoxy)methyl]piperidine
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022995
- Product description3-[(2,4-Dimethylphenoxy)methyl]piperidine
- Packaging500.00mg
- Price$205
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11006198 | 3-((2,4-Dimethylphenoxy)methyl)piperidine 97% | 5g | $648 | 2021-12-16 | Buy |
| Crysdot | CD11006198 | 3-((2,4-Dimethylphenoxy)methyl)piperidine 97% | 5g | $648 | 2026-05-26 | Buy |
| Matrix Scientific | 022995 | 3-[(2,4-Dimethylphenoxy)methyl]piperidine | 500mg | $205 | 2021-12-16 | Buy |
| Matrix Scientific | 022995 | 3-[(2,4-Dimethylphenoxy)methyl]piperidine | 500.00mg | $205 | 2026-05-18 | Buy |
Properties
Boiling point :329.8±22.0 °C(Predicted)
Density :0.976±0.06 g/cm3(Predicted)
pka :9.98±0.10(Predicted)
Density :0.976±0.06 g/cm3(Predicted)
pka :9.98±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|